Navigation
Company
Our Science
mTOR Pathway
TSC1
&
TSC2
nab
Technology Platform
Publications and Abstracts
Our Medicine
Our Medicine
Advanced Malignant PEComa
Pipeline
Patients
Overview
Patient Advocacy
Clinical Trials
Contact Us
General Contact
For Healthcare Professionals
Careers
Archive: April 20, 2018
Home
2018
April
20
20
Apr
2018
Antitumor activity of ABI-009 (
nab
-rapamycin) in combination with anti-PD1 antibody in a syngeneic mouse model of B16 melanoma
0
0
April 20, 2018
April 20, 2018